Feasibility study of CBDCA+TS-1 adjuvant therapy for p-stage IB(T2a>4cm)/II/IIIA non-small cell lung cancer

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2012
This article has no abstract
Epistemonikos ID: 92a9ccddbcf8910508efc79d5beb2e1cfce67471
First added on: Apr 23, 2019